Why Does a Mother Still Get Visits With Her Baby if Baby Tested Pisitive for Meth

J Addict Med. Author manuscript; bachelor in PMC 2016 Mar 1.

Published in final edited form every bit:

PMCID: PMC4374990

NIHMSID: NIHMS644231

Methamphetamines and Pregnancy Outcomes

Tricia Due east. Wright

¹Department of Obstetrics, Gynecology and Women's Wellness, University of Hawaii John A. Burns School of Medicine, 1319 Punahou St. Ste 824, Honolulu, HI 96826, 808-203-6540, 808-955-2174 fax

Renee Schuetter

^twoPath Clinic, Waikiki Health, Honolulu, Hawaii, 845 22nd Ave., Honolulu, Hi 96816

Jacqueline Tellei

²Path Clinic, Waikiki Health, Honolulu, Hawaii, 845 22nd Ave., Honolulu, HI 96816

Lynnae Sauvage

¹Department of Obstetrics, Gynecology and Women'southward Health, University of Hawaii John A. Burns Schoolhouse of Medicine, 1319 Punahou St. Ste 824, Honolulu, HI 96826, 808-203-6540, 808-955-2174 fax

Abstract

Introduction

Methamphetamine (MA) is one of the most commonly used illicit drugs in pregnancy, withal studies on MA-exposed pregnancy outcomes take been express because of retrospective measures of drug use, lack of control for confounding factors: other drug employ, including tobacco; poverty; poor diet; and lack of prenatal care. This study presents prospective nerveless data on MA use and birth outcomes, controlling for most confounders.

Materials and Methods

This is a retrospective accomplice study of women obtaining prenatal care from a clinic treating women with substance use disorders, on whom at that place are prospectively obtained information on MA and other drug use, including tobacco. MA-exposed pregnancies were compared with non-MA exposed pregnancies equally well equally not-drug exposed pregnancies, using univariate and multivariate assay to control for confounders.

Results

One hundred forty-four infants were exposed to MA during pregnancy, 50 had get-go trimester exposure only, 45 had continuous use until the second trimester, 29 had continuous use until the tertiary trimester, but were negative at delivery and xx had positive toxicology at commitment. There were 107 non MA-exposed infants and 59 infants with no drug exposure. Hateful birth weights were the aforementioned for MA-exposed and non-exposed infants (3159 yard vs. 3168 g p=0.9), though smaller than those without any drug exposure (3159 vs. 3321 p=0.04), Infants with positive toxicology at birth (meconium or urine) were smaller than infants with first trimester exposure merely (2932 1000 vs. 3300 g p=0.01). Gestation was significantly shorter among the MA-exposed infants compared to not-exposed infants (38.5 vs. 39.1 weeks p=0.045) and those with no drug exposure (38.v vs. 39.five p=0.0011), The infants with positive toxicology at nascency had a clinically relevant shortening of gestation (37.3 weeks vs. 39.1 p=0.0002).

Conclusions

MA use during pregnancy is associated with shorter gestational ages and lower birth weight, peculiarly if used continuously during pregnancy. Stopping MA employ at whatsoever time during pregnancy improves nativity outcomes, thus resource should be directed towards providing treatment and prenatal care.

Keywords: methamphetamine, pregnancy, birth outcomes, preterm labor, small for gestational age

Introduction

Methamphetamine (MA) is one of the nigh ordinarily abused drugs during pregnancy, with prevalence estimates ranging from 0.seven% to 4.8% in highly endemic areas (Arria et al. 2006, Derauf et al. 2007). Its apply continues to abound world wide (United Nations Function on Drugs and Crime 2013), yet what is known about the effects of utilize during pregnancy is limited by studies using retrospectively gathered data on drug utilize and insufficient controlling for confounding factors, such equally poverty, poor nutrition, lack of prenatal intendance and other drug and tobacco use.

MA acts every bit a competitive inhibitor of the neurotransmitter transporters, specifically serotonin, norepinephrine, and dopamine (Amara and Kuhar 1993, Rudnick and Clark 1993). Among these 3 targets, the serotonin and norepinephrine transporters are expressed abundantly in the placenta (Ganapathy et al. 1999). These transporters are idea to play an important part in homeostasis of the amniotic fluid and fetal circulation (Ganapathy 1993), as well equally command vasoconstriction of the placental vascular bed, which may contribute to the evolution of preeclampsia (Bottalico et al. 2004), intrauterine growth restriction, abruption and preterm labor (Ganapathy 2011).

The studies looking at pregnancy outcomes with MA employ have been conflicting. No consistent teratological effects of in utero MA exposure on the developing human fetus have been identified (Nora et al. 1965, Nora et al. 1970, Levin 1971, Saxen 1975, Dixon and Bejar 1989, Bays 1991, Hansen et al. 1993, Thomas 1995, Stewart and Meeker 1997, Forrester and Merz 2006). Given that women with substance use disorders endure from chaotic lifestyles, research on drug use during pregnancy is fraught with difficulties. Studies of MA-exposed infants endure from methodological bug such as poor compliance, small sample size and multiple other confounding variables, such as the effects of poverty, poor diet, and tobacco use. In studies of other drug employ during pregnancy, these factors take been shown to be equally harmful or more than harmful than the drug use itself (Schempf 2007). There are some data on the effects of MA utilize on maternal complications during pregnancy (Eriksson et al. 1981, Oro and Dixon 1987, Footling et al. 1988, Albertson et al. 1999, Cox et al. 2008), birth weight and gestational age (Oro and Dixon 1987, Niggling et al. 1988, Smith et al. 2003, Smith 2004) and neurodevelopment (Oro and Dixon 1987, Trivial et al. 1988, Gillogley et al. 1990). The Platonic written report, which is the largest written report to date on meth utilize during pregnancy (Nguyen et al. 2010, Shah et al. 2012, Zabaneh et al. 2012) has demonstrated an increased risk of pocket-sized for gestational age, decreased head circumference and length, and NICU admissions, but no increased adventure of pre-eclampsia, abruption, fetal distress, chronic hypertension, or placenta previa.

Of the data on the effects of MA use on maternal complications during pregnancy, two large database studies showed increased complications of pregnancy, controlling for confounders with the use of regression techniques, though neither nerveless data on drug use prospectively. Cox et al (Cox et al. 2008) showed increased risks of hypertension complicating pregnancy, premature rupture of membranes, placenta previa, placental abruption, premature delivery, precipitate labor, infection of amniotic cavity, intrauterine death, and poor fetal growth amidst MA-using women when compared with not-substance using women, but when compared with cocaine-using women, these risks were all lower, with the exception of hypertension complicating pregnancy, which was increased over cocaine. Gorman et al. (Gorman et al. 2014) retrospectively used paired maternal and infant information from the state of California and showed increased risk of gestational hypertension, preeclampsia, IUFD, abruption, preterm nascency, neonatal expiry, and babe death, merely didn't compare with other drug utilize. With the exception of the IDEAL study and the Cox study, previous studies accept been small-scale and defective in controls for other confounding variables such as other drug and tobacco apply. Even in the Ideal written report recruitment was washed at delivery and thus no prospective data on drug use and pregnancy outcome were nerveless.

The current study reports information on women collected prospectively during pregnancy, including dates and amounts of MA and other drug utilize, tobacco and alcohol use, housing and psychosocial factors, pre-existing medical and psychiatric co-morbidities, compliance with prenatal care; and correlates these factors with maternal and infant outcomes.

Methods

The Path clinic was founded in 2007 in Honolulu, Hawaii to provide prenatal intendance for women with addictions. MA is the most common illicit substance used by the women with addictions obtaining intendance at the clinic. Details of the dispensary model and implementation process have been previously reported (Wright et al. 2012). Briefly, the clinic provides prenatal and postpartum intendance for the women, as well as social services, habit counseling and referral to treatment, childcare, assistance with transportation, grouping classes, and tobacco cessation services. Deliveries are washed at two local hospitals by the residents and faculty of the University of Hawaii.

This study analyzes data prospectively collected for quality balls purposes throughout and after the pregnancy. The current accomplice being analyzed obtained care from April 2007 through December 2013. From April 2007 through April 2011, the dispensary was run as a kinesthesia practice through the University of Hawaii. During that time, women who obtained care at the dispensary had either current or past drug use and/or addiction diagnosis. In May 2011, the clinic became function of a larger Federally Qualified Customs Wellness Center and the mission changed to include all women in the catchment area or who were homeless or at take chances of condign homeless, regardless of addiction history.

MA-exposed pregnancies were compared with non MA-exposed pregnancies. The non MA-exposed pregnancies were either women who had a history of MA utilize prior to pregnancy, used tobacco only, used drugs other than MA, or who did not use illicit drugs but obtained care from the dispensary and thus were from the same catchment area and socio-economic status. Screening for MA employ was washed by a combination of validated screening tools (4Ps and 4Ps Plus) on all patients, likewise equally questioning on recent drug use on patients with a history of addiction at each visit. Random toxicology was done throughout pregnancy and every bit indicated by clinical or social concerns (i.e. missed appointments). MA apply was noted in the database in a semi-quantitative manner, using patient self-written report of use of corporeality and frequency (daily, twice weekly, monthly). Last reported utilize was noted in the chart. The majority of women with a history of addiction had toxicology done at the fourth dimension of birth (urine, meconium or both). Positive toxicology at birth was considered either a positive maternal or neonatal urine toxicology, as meconium can theoretically reflect maternal use many months before delivery. Not-MA exposed women were those who denied whatsoever drug use on validated screening tools or those with a past history of drug use and negative toxicology. The authors input all data into the database directly from the medical nautical chart, including medical and psychiatric co-morbidities, number of prenatal visits, substance use, referral sources, housing situation, and pregnancy complications. Birth outcomes were obtained shortly later delivery by brainchild from the electronic medical records of the ii delivery hospitals. The University of Hawaii Committee on Human Studies reviewed the project and found it to be exempt from consent requirements in society to report clinical outcomes.

Sample size calculations were performed using birth weight as the chief outcome variable. To detect a 250 g difference in birth weight, using a power of eighty% and two-tailed α of 0.05, 36 infants in each group were required. Information were summarized by descriptive statistics. Dichotomous data were compared using Chi-squared tests and continuous data were compared using student'due south t-tests.

The clan between MA and two primary outcomes of interest, preterm commitment and SGA, were and so evaluated using multiple logistic regression, adapted for important covariates. The covariates that were identified to be associated with the outcomes variables with a p-value <0.05 on univariate analysis were used in the multivariable model. Adjusted odds ratios and their 95% Confidence Intervals were obtained.

Results

At that place were 251 live births amongst the cohort that obtained intendance between April 2007 and December 2013. In that location were five sets of twins, two in the meth-exposed and three in the non-meth exposed groups. In that location were 4 third trimester intrauterine fetal deaths (IUFD) during this time (3 meth-exposed, 2 positive for CMV exposure and 1 with Down's syndrome, cardiac defect and duodenal atresia and i non meth-exposed without other chance factors other than advanced maternal age). The IUFDs were removed from further assay. Of the 251 live births, 107 had no meth exposure, 50 had first trimester exposure only, 45 had continuous employ until the 2d trimester, 29 had continuous use until the third trimester, but were negative at delivery and 20 had positive toxicology at delivery. Demographics are presented in tabular array 1.

Tabular array 1

Summary of demographics

	All women in study (north=251)					Women with no other drug use (n=119)
	Any MA utilize during pregnancy n=144		No MA employ during pregnancy n=107			Only MA use during pregnancy due north=60		No drug use during pregnancy n=59
	Mean ± SD	Range	Mean ± SD	Range	p-value	Mean ± SD	Range	Mean ± SD	Range	p-value
Maternal Age (years)	28.6 ± 6.one	(xvi–45)	28.iv ± 6.1	(14–41)	0.65	28.4 ± 6.vii	(16–45)	29.1 ± v.5	(18–41)	0.52
Gravidity	iv.ix ± 3	(one–12)	3.5 ± 2.five	(1–15)	<0.0001	iv.8 ± 3.5	(1–xv)	3.6 ± ii.5	(1–fifteen)	0.02
Parity	2.v ± two.1	(0–9)	1.5 ± ane.6	(0–6)	<0.0001	2.2 ± 2.ii	(0–8)	1.7 ± i.vii	(0–6)	0.16
Aborta	1.four ± 2.one	(0–12)	1.1 ± 1.seven	(0–eleven)	0.12	1.6 ± 2.3	(0–12)	0.9 ± 1.1	(0–11)	0.08
Master Ethnicity north=239 *	n	%	northward	%		n	%	northward	%	p-value
Caucasian	27	xx.1	44	41.9	0.0004	14	25.0	18	31.vi	0.57
NH/OPI	76	56.seven	34	32.three	0.0003	30	53.6	22	38.vi	0.sixteen
Asian	10	7.5	fifteen	fourteen.ii	0.17	iv	7.ane	9	15.viii	0.15
Filipina	viii	6.0	4	three.8	0.65	three	5.four	3	5.3	ane.00
African American	4	3.0	iii	2.9	i.00	ii	iii.6	2	3.5	i.00
Hispanic	vii	v.0	5	four.8	i.00	ii	3.half-dozen	3	5.iii	1.00
Other substance use	n	%	northward	%	p-value	n	%	northward	%	p-value
Smoker (any during pregnancy) due north=241	124	89.9	fourscore	77.7	0.01	54	91.5	39	72.ii	0.01
Alcohol n=233	xviii	14.0	13	12.5	0.75	0	0	0	0	NA
Cocaine n=238	six	4.5	5	4.eight	0.93	0	0	0	0	NA
Heroin n=251	6	four.2	2	one.9	0.47	0	0	0	0	NA
Marijuana n=239	44	32.6	16	15.4	0.002	0	0	0	0	NA
Other opioid utilise northward=233	nine	vi.3.	21	xix.4	0.002	0	0	0	0	NA
Co-occurring mental health disorders	n	%	n	%	p-value	northward	%	n	%	p-value
Mood disorder n=246	64	45.i	41	39.1	0.38	32	53.iii	21	36.ii	0.06
Schizophrenia/Schizoaffective n=245	eight	5.6	0	0	0.02	3	v.0	0	0	0.24
PTSD n=245	26	18.three	11	10.68	0.09	15	25.0	vi	10.5	0.04
Whatever co-occurring disorder northward=246	72	50.7	44	42.3	0.19	35	59.3	25	42.iv	0.06

Women who used MA had college gravidity and parity and were more probable to smoke cigarettes and employ marijuana during pregnancy. Cocaine and alcohol apply was similar between the two groups. The non MA-using grouping was more than likely to apply other opioids and exist Caucasian. Interestingly the grouping who didn't use any drugs at all during their pregnancy more closely resembled the non-MA group. Heroin apply was depression in both groups reflecting the low prevalence of heroin utilize in Hawaii. As noted in previous studies (Wright and Tam 2010), Native Hawaiian and other Pacific Islander (NH/OPI) were overrepresented in the MA-using group. Schizophrenia/schizoaffective disorders and PTSD were more common among the MA-using women.

Univariate analyses of birth outcomes are presented in Table 2. MA-using women presented significantly later for prenatal care and had fewer prenatal visits. There was no departure in nascency weight between the MA-using group and the non MA-using group, though the gestational historic period at delivery was slightly younger (6/ten of a week). The not-drug using group had a significantly longer gestational age (i week) and was 176 g heavier than the MA-using group and the grouping that used other drugs. They had a bigger head circumference and were longer. There was no departure in the incidence of preterm commitment, preterm premature rupture of membranes, abruption, non-reassuring centre rate, chorioamnionitis, asthma, diabetes, low-nativity weight, sepsis, intraventricular hemorrhage, necrotizing enterocolitis, or NICU access between the MA-exposed newborns and the non-MA exposed newborns. At that place was a meaning increase in chronic hypertension and cesarean delivery associated with MA use and a not-meaning increase in the incidence of preeclampsia. The bulk of cesarean sections were repeat.

Table 2

Birth Outcomes of MA-exposed pregnancies compared with not-MA exposed pregnancies

	All women (north=251)			Women with no other drug use (n=119)
	Whatsoever MA utilize during pregnancy due north=144	No MA use during pregnancy n=107		Merely MA during pregnancy north=60	No drug use during pregnancy north=59
Outcome	Mean ± SD	Mean ± SD	p-value	Mean ± SD	Mean ± SD	p-value
Gestational age (weeks)	38.5 ± ii.0	39.ane ± ii.i	0.048	38.viii ± 2.1	39.five ± 1.half-dozen	0.043
Birth Weight (grams)	3159 ± 561	3168 ± 533	0.9	3103 ± 537	3321 ± 451	0.019
Head Circumference (cm)	33.5 ± three.two	33.nine ± 2.ix	0.42	33.2 ± 3.iv	34.6 ± one.v	0.01
Length (cm)	50.3 ± 3.0	50.6 ± 3.four	0.52	49.8 ± 3.4	51.3 ± two.5	0.009
Cord pH	vii.25 ± 0.1	vii.27 ± 0.1	0.18	7.25 ± 0.ane	vii.27 ± 0.ane	0.26
Maternal LOS (days)	2.vii ± 1.three	ii.4 ± i.2	0.12	2.52 ± 0.9	2.2 ± 0.8	0.02
Infant LOS (days)	3.9 ± 7.0	three.5 ± 4.7	0.62	iv.three ± vii.8	ii.5 ± ane.nine	0.ane
First prenatal visit (weeks)	23.3 ± 9.v	17.7 ± ix.5	<0.0001	24.2 ± ix.4	17.2 ± 10.four	0.0009
Number of prenatal visits	7 ± iv.3	viii.4 ± 3.9	0.018	vii.five ± 4.4	eight.six ±4.two	0.22

Figures one and ​ 2 show gestational age and nativity weight stratified by trimester of last apply of MA. Significantly only women who continued to utilise throughout pregnancy delivered early on and had smaller babies. This was also truthful when compared with women who didn't use whatever drugs during their pregnancies. In addition, women who continued to employ MA throughout their pregnancies were significantly more likely to have inadequate prenatal care. (68% vs. 18% p<0.0001).

Comparison of hateful gestational historic period with trimester of last employ of methamphetamines. Every bit the data points show, the corporeality of women using MA decreased throughout pregnancy. Mean gestational ages were not different between whatever utilize and use in trimesters i–three. Only utilize at the fourth dimension of delivery was associated with shorter gestation (p=0.0145*).

Comparison of hateful birth weight past final trimester of methamphetamine utilise. Women with positive toxicology at birth had lower unadjusted nativity weights than those that stopped in 1^st or iii^rd trimester (p=0.04*).

In that location were 5 major birth defects amongst the 251 births (2%). Of these 3 were MA exposed (cardiac defect, portal vein anomaly, and cystic hygroma) and two were non-MA exposed (bilateral ventriculomegaly and laryngiomalacia). There were 3 pocket-sized nascence defects (1 MA exposed and 2 non-MA exposed).

Multivariate analyses are presented in tables 3–4. In the multivariate logistic model, using insufficient prenatal intendance (<five visits), chronic hypertension, preeclampsia and diabetes, trimester of last MA use, and other drug utilize (divers as any other illicit drug use also MA) every bit covariates, but persistent MA utilize (positive toxicology at birth) and other drug use were associated with preterm delivery. Persistent MA use was associated with iii.5-fold increase in preterm delivery and other drug use with a two.iv-fold increase. Interestingly smoking was non associated with preterm delivery in this model on univariate or multivariate analysis. Each week of delaying prenatal care increased the odds of delivering preterm by i.07 (one.01–1.xv) p=0.043.

Tabular array 3

Unadjusted associations betwixt Pregnancy complications and MA use

	All women (northward=251)				Women with no other drug use (north=119)
	Whatsoever MA apply during pregnancy northward=144	No MA employ during pregnancy n=107			Only MA during pregnancy n=threescore	No drug use during pregnancy n=59
Pregnancy Complications	north (percent)	northward (percent)	OR (95%CI)	p-value	n (per centum)	n (percent)	OR (95%CI)	p-value
Preterm delivery	18 (12.6)	xiii (12.0)	1.05 (0.5–2.3)	1.00	eight (13)	3 (5)	ii.8 (0.vii–11.2)	0.2
Depression nativity weight	15 (10.seven)	10 (9.4)	1.2 (0.v–2.vii)	0.83	8 (xiii)	ii (iii.4)	4.iii (0.9–21.ii)	0.09
Chronic Hypertension	11 (7.vii)	ii (1.9)	4.4 (0.nine–twenty.two)	0.035	3 (four.9)	0 (0)	NA	0.24
Preeclampsia	10 (vii.0)	4 (3.7)	ane.94 (0.6–6.3)	0.28	4 (6.6)	2 (3.4)	ii.0 (0.four–11.5)	0.68
Cesarean Delivery	46 (32.ii)	fifteen (12.0)	2.9 (1.five–5.vi)	0.0006	12 (nineteen.seven)	iv (half dozen.8)	3.4 (1.0–11.ane)	0.058
NICU Admission	10 (7.3)	10 (9.6)	0.74 (0.3–1.9)	0.63	iv (6.viii)	two (iii.6)	1.9 (0.3–11.0)	0.68
Small for gestational historic period	fifteen (10.v)	15 (14.0)	0.72 (0.3–1.five)	0.43	8 (xiii)	6 (ten.3)	1.3 (0.iv–four.0)	0.78

Table iv

Multiple logistic regression of preterm delivery (<37 weeks)

Variable	aOR (95% CI)	p-value
Insufficient prenatal care (<v visits)	2.11 (0.77–5.49)	0.14
Chronic Hypertension	3.53 (0.68–16.twoscore)	0.xiii
Pre-eclampsia	two.30 (0.38–x.64)	0.33
Diabetes	ii.27 (0.60–7.32)	0.21
Other drugs	2.40 (one.01–6.00)	0.048
MA-positive at delivery	3.54 (1.02–11.66)	0.046
Delayed prenatal care (per week)	1.07 (ane.01–1.xv)	0.043

Persistent smoking, but not MA employ, nor other drug utilize, was associated with pocket-size for gestational historic period (SGA), defined every bit a baby measuring <10% for gestational historic period using Alexander's algorithm (Alexander et al. 1996).

Discussion

This is the largest cohort report of methamphetamine-exposed pregnancies to date where information on MA and other drug use was nerveless prospectively. In add-on, the groups are similar in the presence of other confounding factors, including tobacco use (90% vs. 78% vs. state average 12%), other drug use, poverty levels (98% of women in the written report were on State Medicaid) and housing condition (the keen majority of women (>xc%) in each grouping were either in residential drug treatment, homeless or at-risk homeless, or incarcerated). All the non MA-using women either had a past history of addiction or were either from the same catchment area equally the meth-using women, and homeless or at-hazard for becoming homeless. Given the similarities in these factors, we showed that continuous MA and other drug use are associated with lower gestational historic period and nascency weight, but that any MA use during pregnancy is not associated with adverse pregnancy outcomes other than chronic hypertension and cesarean commitment. Women who continually used MA throughout pregnancy did have a higher chance of delivering preterm. We did show that women who stop using MA at any time during pregnancy accept improved birth outcomes as far as birth weight and gestational age, and these do not differ from women who do non employ MA during pregnancy. Reassuringly MA use was not associated with whatever increment in nativity defects in a higher place baseline.

The Ideal study has a larger enrollment, every bit it is a multi-middle written report (Arria et al. 2006, Smith et al. 2006). Still enrollment in that report was done at nascency and data on MA employ was collected retrospectively. In addition, the command grouping was non matched for socio-economic status. In contrast to the IDEAL report (Smith et al. 2006), we did non show an increase in pocket-size for gestational age (SGA) in the MA-exposed infants. The MA-exposed infants were smaller, but not in one case controlled for the earlier gestational age. We did bear witness an increase risk of maternal chronic hypertension with MA utilise, which is consistent with other studies that show a multitude of cardiovascular effects from chronic MA employ (Carvalho et al. 2012). Information technology could be that this is the mechanism causing SGA in the Ideal report.

The increment in cesarean deliveries could exist secondary to the increased gravidity and parity of the MA-using women as the majority of cesarean deliveries were for the indication of prior cesarean. Before the institution of the dispensary, many of these women did not go prenatal care and often ended upwardly at the hospital with complications necessitating cesarean delivery that could've been prevented with adequate prenatal care, (e.g. breech presentation where external cephalic version could be offered or ameliorate blood force per unit area control during pregnancy so that tardily preterm delivery would not be necessary for uncontrolled hypertension). Even in this report, women who used MA entered prenatal care later on and had fewer prenatal visits, and women who persisted using MA were much more than probable to take inadequate prenatal care, which volition increment the rate of pregnancy complications. Even in patients with drug utilize throughout pregnancy, prenatal care of at least 4 visits has been shown to improve pregnancy outcomes (El-Mohandes et al, 2009). Presenting tardily to care also makes it less likely the pregnancy will exist accurately dated, which may inadvertently increase the preterm delivery rate, every bit dating depends on early on ultrasound or clinical exam. For example, if a adult female presents at xxx weeks for care, her pregnancy dating ultrasound may be off by up to 3 weeks. If she and so goes on to deliver at 36 weeks past that dating, she would be considered preterm, just in actuality may be 39 weeks and full-term. Inversely if she were considered 39 weeks, merely was really simply 36 weeks, she may iatrogenically be delivered preterm.

This study has many limitations. The women in the dispensary were cocky-selected and often motivated to quit using MA, which near probable improved compliance with prenatal intendance and other cocky-care practices. This could exist reflected in the fact that women who continued to use until delivery had worse pregnancy outcomes. There is somewhat limited generalizability to other communities, given depression rates of heroin usage and less exposure to multiple drugs other than marijuana and tobacco. In addition, we didn't have extremely accurate assessment of alcohol usage and no data on weight proceeds was collected, which can influence the incidence of SGA. In improver, strict measurements of socio-economic status (SES) were not collected, thus Medicaid-eligibility was used equally a proxy measure. This information volition be collected going frontwards. In addition, further studies on baby development should be done.

Conclusion

Continuous methamphetamine apply during pregnancy is associated with preterm delivery and low-birth weight, both of which contribute to neonatal morbidity and mortality. The majority of women in the study stopped using MA (86%), which is extremely reassuring. The women that did terminate engaged in prenatal care more than often and had normal birth outcomes. Stopping MA use at whatsoever time during pregnancy improves nascence outcomes, thus resources should exist aimed at handling of addiction and promotion of prenatal care.

​

Tabular array 5

Multiple logistic regression of minor for gestational age (<10%)

Variable	aOR (95% CI)	p-value
Persistent Smoker	4.58 (1.90–12.80)	0.0004
MA-positive at delivery	0.34 (0.01–i.83)	0.24
Other drugs	ane.69 (0.77–3.80)	0.19

Supplementary Material

Supplemental Data File _doc_ pdf_ etc._

Acknowledgments

Funding for the institution for the Path dispensary was given by the Hawaii State Legislature (Acts 248–2006 and 147–2007). Funding for clinical outcomes studies was provided in role past NIH grant 5U54RR014607. Funding for statistical review was provided by NIH grants U54MD007584 and G12MD007601. Philanthropic support was provided by the Office of Hawaiian Affairs, The Hawaii Community Foundation, Healthy Mothers, Healthy Babies-Hawaii, March of Dimes Hawaii and other customs members. The Salvation Army Family Handling Center has promoted our peaceful coexistence these many years. Thank you to Jennifer Elia and Dr. John Chen for reviewing the paper draft and cheers to the many clinic staff and volunteers, without whom the clinic would non have such outcomes, especially Bernadette Scanlan-Hodges Julia Yoshimoto, and Rachel Dorr, Cynthia Nguyen, Christina Mail, Shyna Estubio, Kelly Meyers and Porsha Arnold.

Footnotes

The authors report no relevant conflicts of involvement

Data from this study was presented in abstract grade at the following meetings:

III Global Congress of Maternal and Infant Health, Buenos Aires, Argentina, November 2013

American Gild of Addiction Medicine, Orlando, FL Apr 2014

American College of Obstetrics and Gynecology Almanac Clinical Meeting. Chicago, IL April, 2014

References

• Albertson TE, Derlet RW, Van Hoozen BE. Methamphetamine and the expanding complications of amphetamines. West J Med. 1999;170(iv):214–219. [PMC free commodity] [PubMed] [Google Scholar]
• Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan MA. Us national reference for fetal growth. Obstet Gynecol. 1996;87(2):163–168. [PubMed] [Google Scholar]
• Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73–93. [PubMed] [Google Scholar]
• Arria AM, Derauf C, Lagasse LL, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Babe Development, Surroundings, and Lifestyle (Platonic) written report. Matern Child Wellness J. 2006;x(3):293–302. [PubMed] [Google Scholar]
• Bays J. Fetal vascular disruption with prenatal exposure to cocaine or methamphetamine. Pediatrics. 1991;87(3):416–418. [PubMed] [Google Scholar]
• Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslen B, Marsal K, Hansson SR. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in homo placenta from pre-eclamptic and normotensive pregnancies. Placenta. 2004;25(vi):518–529. [PubMed] [Google Scholar]
• Carvalho M, Carmo H, Costa VM, et al. Toxicity of amphetamines: an update. Arch Toxicol. 2012;86(eight):1167–1231. [PubMed] [Google Scholar]
• Cox Southward, Johnson CH, Meikle South, Jamieson DJ, Posner SF. Trends in rates of hospitalization with a diagnosis of substance abuse among reproductive-age women, 1998 to 2003. Womens Health Issues. 2007;17(2):75–83. [PubMed] [Google Scholar]
• Cox S, Posner SF, Kourtis AP, Jamieson DJ. Hospitalizations with amphetamine corruption among significant women. Obstet Gynecol. 2008;111(2):341–347. [PubMed] [Google Scholar]
• United Nations Role on Drugs and Law-breaking. Globe Drug Written report. 2013 Bachelor at http://www.unodc.org/wdr/. Accessed Accessed June 16, 2014.
• Derauf C, LaGasse LL, Smith LM, et al. Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, surround, and lifestyle study (Platonic) Am J Drug Booze Abuse. 2007;33(two):281–289. [PMC complimentary article] [PubMed] [Google Scholar]
• Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr. 1989;115(5 Pt 1):770–778. [PubMed] [Google Scholar]
• El-Mohandes A, Herman AA, Nabil El-Khorazaty M, Katta PS, White D, Grylack 50. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol. 2009;23(5):354–360. [PubMed] [Google Scholar]
• Eriksson One thousand, Larsson G, Zetterstrom R. Amphetamine addiction and pregnancy. Two. Pregnancy, commitment and the neonatal period. Socio-medical aspects. Acta Obstet Gynecol Scand. 1981;60(3):253–259. [PubMed] [Google Scholar]
• Forrester MB, Merz RD. Comparison of trends in gastroschisis and prenatal illicit drug use rates. J Toxicol Environ Health A. 2006;69(xiii):1253–1259. [PubMed] [Google Scholar]
• Ganapathy V. Drugs of abuse and homo placenta. Life Sci. 2011;88(21–22):926–930. [PMC free article] [PubMed] [Google Scholar]
• Ganapathy Five, Ramamoorthy S, Leibach FH. Transport and metabolism of monoamines in the human placenta. Trophoblast Res. 1993;seven:35–51. [Google Scholar]
• Ganapathy VV, Prasad PD, Ganapathy ME, Leibach FH. Drugs of corruption and placental send. Adv Drug Deliv Rev. 1999;38(i):99–110. [PubMed] [Google Scholar]
• Gillogley KM, Evans AT, Hansen RL, Samuels SJ, Batra KK. The perinatal bear upon of cocaine, amphetamine, and opiate utilise detected by universal intrapartum screening. Am J Obstet Gynecol. 1990;163(5 Pt 1):1535–1542. [PubMed] [Google Scholar]
• Gorman MC, Orme KS, Nguyen NT, Kent EJ, Caughey AB. Outcomes in Pregnancies Complicated by Methamphetamine Use. Am J Obstet Gynecol. 2014 E-pub ahead of print. [PubMed] [Google Scholar]
• Hansen RL, Struthers JM, Gospe SM. Visual evoked potentials and visual processing in stimulant drug-exposed infants. Dev Med Child Neurol. 1993;35(9):798–805. [PubMed] [Google Scholar]
• Levin JN. Amphetamine ingestion with biliary atresia. J Pediatr. 1971;79(1):130–131. [PubMed] [Google Scholar]
• Little BB, Snell LM, Gilstrap LC. Methamphetamine abuse during pregnancy: outcome and fetal furnishings. Obstet Gynecol. 1988;72(4):541–544. [PubMed] [Google Scholar]
• Nguyen DL, Smith One thousand, Lagasse LL, et al. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the babe development, environment, and lifestyle study. J Pediatr. 2010;157(two):337–339. [PMC free article] [PubMed] [Google Scholar]
• Nora JJ, Trasler DG, Fraser FC. Malformations in mice induced by dexamphetamine sulphate. Lancet. 1965;2(7420):1021–1022. [PubMed] [Google Scholar]
• Nora JJ, Vargo TA, Nora AH, Honey KE, McNamara DG. Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet. 1970;i(7659):1290–1291. [PubMed] [Google Scholar]
• Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987;111(iv):571–578. [PubMed] [Google Scholar]
• Rudnick Thou, Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta. 1993;1144(3):249–263. [PubMed] [Google Scholar]
• Saxen I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol. 1975;4(ane):37–44. [PubMed] [Google Scholar]
• Schempf A. Illicit drug use and neonatal outcomes: a critical review. Obstet Gynecol Surv. 2007 Nov;62(11):749–757. [PubMed] [Google Scholar]
• Shah R, Diaz SD, Arria A, et al. Prenatal methamphetamine exposure and short-term maternal and babe medical outcomes. Am J Perinatol. 2012;29(5):391–400. [PMC free article] [PubMed] [Google Scholar]
• Smith 50, LaGasse L, Derauf C, Lester B. Intrauterine Growth of Infants Exposed to Prenatal Methamphetamine: Preliminary Results from the Infant Development, Surroundings, and Lifestyle Study (IDEAL) Pediatric Research. 2004;55:72A. [Google Scholar]
• Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr. 2003;24(1):17–23. [PubMed] [Google Scholar]
• Smith LM, LaGasse LL, Derauf C, et al. The baby evolution, environment, and lifestyle study: furnishings of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics. 2006;118(3):1149–1156. [PubMed] [Google Scholar]
• Stewart JL, Meeker JE. Fetal and infant deaths associated with maternal methamphetamine corruption. J Anal Toxicol. 1997;21(6):515–517. [PubMed] [Google Scholar]
• Thomas DB. Cleft palate, bloodshed and morbidity in infants of substance abusing mothers. J Paediatr Child Health. 1995;31(5):457–460. [PubMed] [Google Scholar]
• Wright TE, Schuetter R, Fombonne E, Stephenson J, Haning WF. Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduct J. 2012;ix(1):v. [PMC costless article] [PubMed] [Google Scholar]
• Wright TE, Tam E. Disparate rates of persistent smoking and drug use during pregnancy of women of Hawaiian ancestry. Ethnicity and Disease. 2010;xx(1 Suppl one):S1–215–218. [PubMed] [Google Scholar]
• Zabaneh R, Smith LM, LaGasse LL, et al. The effects of prenatal methamphetamine exposure on childhood growth patterns from nascency to 3 years of historic period. Am J Perinatol. 2012;29(3):203–210. [PMC free article] [PubMed] [Google Scholar]

singerefored.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374990/

Share this post